20-FThe Record
China SXT Pharmaceuticals, Inc. files 20-F
Filed Jul 1, 2026 · 12d ago · Accession 0001213900-26-074310
Plain English
China SXT Pharmaceuticals, Inc. reported a net loss of $6,205,085 for the fiscal year ended March 31, 2026, an 88% increase in net loss compared to the prior year. This was primarily driven by a significant increase in general and administrative expenses, which included a $5,305,739 employee incentive.
Filing details
- Ticker
- SXTC
- CIK
- 1723980
- Form type
- 20-F
- Filing date
- Jul 1, 2026
- Report date
- Mar 31, 2026
- Document
- ea0295524-20f_chinasxt.htm
- Size
- 9.7 MB